logo
Select company
Select metric
$ -10.32MFree Cash Flow
VS
Market
29
Sector
57
Industry
77
History
-
$ 1.11Close
$ 0.77 - $ 1.54 52-Week Range
Ticker Information

Ticker

RNXT

Company Name

RENOVORX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RENOVORX INC - Free Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNXT - FCF Historical data
DateCapital ExpenditureFree Cash FlowNet Cash Flow - Operations
6/30/2025$ 14K$ -10.32M$ -10.31M
3/31/2025$ 14K$ -10.32M$ -10.3M
12/31/2024$ 12K$ -9.14M$ -9.13M
9/30/2024$ 0$ -8.75M$ -8.75M
6/30/2024$ 0$ -9.28M$ -9.28M
3/31/2024$ 0$ -9.76M$ -9.76M
12/31/2023$ 0$ -10.26M$ -10.26M
9/30/2023$ 0$ -9.89M$ -9.89M
6/30/2023$ 0$ -9.83M$ -9.83M
3/31/2023$ 0$ -9.42M$ -9.42M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RENOVORX INC's latest trailing twelve months (TTM) FCF stands at $ -3.53M.
  • Over the past 5 years, RENOVORX INC's average FCF has been $ -8.92M.
  • The median FCF for RENOVORX INC during this period was $ -9.55M
  • RENOVORX INC reached its highest FCF over the past 5 years at $ -3.53M.
  • The lowest FCF recorded by RENOVORX INC in the same timeframe $ -10.32M

RENOVORX INC's FCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Benchmarks
CompanyFCF
ADVM : ADVERUM BIOTECHNOLOGIES INC $ -131.53MRLYB : RALLYBIO CORP $ -41.99MICU : SEASTAR MEDICAL HOLDING CORP $ -15.36MLEXX : LEXARIA BIOSCIENCE CORP $ -9.77MCLNN : CLENE INC $ -17.64MCOEP : COEPTIS THERAPEUTICS HOLDINGS INC $ -8.09MBRTX : BIORESTORATIVE THERAPIES INC $ -9.63MVTGN : VISTAGEN THERAPEUTICS INC $ -50.29MLYRA : LYRA THERAPEUTICS INC $ -43MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -10.31M

Definition of Free Cash Flow

[Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
CF - Operations - CapEx
(=) FCF
FCF for RENOVORX INC is calculated as follows: CF - Operations [ $ -3.53M ] - CapEx [ $ 0 ]
(=) FCF [ $ -3.53M ]

RNXT - Free Cash Flow, Last 5 years

$ -10.32M

Minimum

Jun 30, 2025

$ -3.53M

Maximum

Dec 31, 2020

$ -8.92M

Average

$ -9.55M

Median

FCF Benchmark Analysis

The chart above depicts the distribution of FCF for companies in the Total Stock Market. The average FCF of the companies is $ 28.88M with a standard deviation of $ 118.08M.
The following table provides additional summary stats:
FCF in the Market:
filtered constituents3.3K
min$ -356.66M
max$ 390M
average$ 28.88M
median$ 565K
std$ 118.08M